FDANonrulemakingFDA-2019-D-4447
Who commented on this docket
Transdermal and Topical Delivery Systems - Product Development and Quality Considerations; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Transdermal and Topical Delivery Systems - Product Development and Quality Considerations; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2351d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 2351d ago
Commenters (1)
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.